Get the Stockscreener App
13.31
0.15%
-0.02
After Hours:
13.31
Organon Co stock is traded at $13.31, with a volume of 4.84M.
It is down -0.15% in the last 24 hours and up +50.74% over the past month.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
See More
Previous Close:
$13.33
Open:
$13.34
24h Volume:
4.84M
Relative Volume:
0.55
Market Cap:
$3.50B
Revenue:
$6.16B
Net Income/Loss:
$246.00M
P/E Ratio:
14.18
EPS:
0.9387
Net Cash Flow:
$708.00M
1W Performance:
-0.30%
1M Performance:
+50.74%
6M Performance:
+72.63%
1Y Performance:
+52.81%
1-Day Range:
$13.28
$13.34
1-Week Range:
$13.28
$13.44
52-Week Range:
$5.69
$13.44
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, AZN, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.31 | 3.50B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
989.87 | 862.31B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
224.26 | 533.03B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
207.86 | 358.27B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
184.54 | 282.04B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
148.16 | 277.11B | 54.66B | 13.58B | 16.05B | 7.0171 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Oct-27-25 | Downgrade | Piper Sandler | Overweight → Underweight |
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Organon & Co is the best performing healthcare stock in April - MSN
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN
Sun Pharma shares jump after Organon acquisition deal; top gainer on Nifty 50 - MSN
Mega Sun Pharma-Organon Deal | Organon A Strategic Fit For Sun Pharma, Says Macquarie Capital (Wch7sn8ZBU) - fathomjournal.org
Organon & Co. Opens with 23.72% Gain, Surpassing S&P 500's 0.8% Rise - Markets Mojo
Sun Pharma shares jump 9% as $11.75‑billion Organon buy seals entry into biosimilars, deal expected to close in 2027 - MSN
Win-win deal! Sun Pharma jumps 8% in two days with Organon zooming 42% in five daysAll about acquisition - MSN
Organon & Co (OGN) News Flow - Moomoo
What does Sun Pharma gain from its $12-billion Organon bid? - MSN
Sun Pharma’s $11.75 Billion Organon Deal: Dilip Shanghvi’s Bold Move Taking India to the World - Open Magazine
Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN
India's largest drugmaker Sun Pharma to buy US firm Organon in $11.75 billion deal; shares jump 7% - MSN
Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma - MSN
MSN Money - MSN
India’s Sun Pharma takes biosimilar leap with $11.75 billion all-cash Organon acquisition - MSN
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
'Buy' Sun Pharma shares: Up to 34% upside? What experts say on India's biggest ever pharma deal Organon - MSN
BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN
Sun Pharma to acquire Organon in $11.75 billion deal; eyes global top 25 spot - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
OGN (OGN) Form 144: multiple RSU vestings and dividend-equivalent share listings - Stock Titan
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Organon & Co To Go Ex-Dividend On May 11th, 2026 With 0.02 USD Dividend Per Share - Moomoo
Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat
India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN
Sun Pharmaceutical share: Brokerages turn bullish post Organon deal, peg up to 16% upside; check latest target prices - MSN
Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more - MSN
Organon SVP, corporate controller Holzbaur sells $353,080 stock By Investing.com - Investing.com Australia
Organon SVP, corporate controller Holzbaur sells $353,080 stock - Investing.com
Organon (OGN) controller sells 26,448 shares, ends direct stake - Stock Titan
OGN SEC FilingsORGANON & CO 10-K, 10-Q, 8-K Forms - Stock Titan
Organon Insider Bought Shares Worth $353,080, According to a Recent SEC Filing - marketscreener.com
OGN | Organon & Co. FinancialsIncome Statement - Quiver Quantitative
Organon SVP Lynette Holzbaur acquires $353,080 in company stock By Investing.com - Investing.com South Africa
Organon SVP Lynette Holzbaur acquires $353,080 in company stock - Investing.com
Organon (OGN) controller boosts stake with 26,448-share purchase - Stock Titan
Organon & Co stock hits 52-week high at 13.4 USD - Investing.com Australia
Organon Buyout By Sun Pharma Shifts Focus To Cash Value And Timing - Yahoo Finance
Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results - Moomoo
Organon & Co stock hits 52-week high at 13.4 USD By Investing.com - Investing.com South Africa
How big is Organon’s biosimilar push for Sun Pharma? - MSN
Sun Pharma Signs Definitive Agreement to Acquire Organon & Company in $11.75 Billion Deal - scanx.trade
Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire - Mint
Sun Pharma explores funding mix for $12 billion Organon deal - ET Pharma
Organon shares rally 16% in premarket as Sun Pharma announces buyout - MSN
Sun Pharma to acquire Organon for $11.75bn - MSN
Bonds, Loans and a Bold Leap: Inside Sun Pharma's Plan to Finance $12-Bn Organon Deal - outlookbusiness.com
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):